Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-09-18

Clinical Trial Update: Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing whether adding Vitamin C supplementation to standard hypoglycemic therapy improves outcomes in Type 2 diabetes mellitus compare…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypoglycemic agents (various)
  • Vitamin C supplementation (ascorbic acid)

Snippet

Sponsor: Al-Neelain University | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: UNKNOWN